Myung In Pharmaceutical LTD. (KRX:317450)

KRX:317450 Statistics

Total Valuation

KRX:317450 has a market cap or net worth of KRW 1.07 trillion. The enterprise value is 600.91 billion.

Market Cap	1.07T
Enterprise Value	600.91B

Important Dates

The next estimated earnings date is Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

KRX:317450 has 14.60 million shares outstanding. The number of shares has increased by 0.59% in one year.

Current Share Class	14.60M
Shares Outstanding	14.60M
Shares Change (YoY)	+0.59%
Shares Change (QoQ)	+2.26%
Owned by Insiders (%)	70.38%
Owned by Institutions (%)	3.42%
Float	4.32M

Valuation Ratios

The trailing PE ratio is 11.49.

PE Ratio	11.49
Forward PE	n/a
PS Ratio	3.79
PB Ratio	1.39
P/TBV Ratio	1.40
P/FCF Ratio	19.31
P/OCF Ratio	13.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.84, with an EV/FCF ratio of 10.80.

EV / Earnings	8.33
EV / Sales	2.12
EV / EBITDA	5.84
EV / EBIT	6.64
EV / FCF	10.80

Financial Position

The company has a current ratio of 14.27, with a Debt / Equity ratio of 0.00.

Current Ratio	14.27
Quick Ratio	12.75
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.03
Interest Coverage	337.64

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	11.70%
Revenue Per Employee	845.69M
Profits Per Employee	215.46M
Employee Count	335
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, KRX:317450 has paid 19.98 billion in taxes.

Income Tax	19.98B
Effective Tax Rate	21.68%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	29.00
Average Volume (20 Days)	204,369

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:317450 had revenue of KRW 283.31 billion and earned 72.18 billion in profits. Earnings per share was 6,407.02.

Revenue	283.31B
Gross Profit	172.39B
Operating Income	90.56B
Pretax Income	92.16B
Net Income	72.18B
EBITDA	102.82B
EBIT	90.56B
Earnings Per Share (EPS)	6,407.02

Balance Sheet

The company has 475.35 billion in cash and 1.70 billion in debt, giving a net cash position of 473.65 billion or 32,441.85 per share.

Cash & Cash Equivalents	475.35B
Total Debt	1.70B
Net Cash	473.65B
Net Cash Per Share	32,441.85
Equity (Book Value)	771.70B
Book Value Per Share	67,358.49
Working Capital	563.66B

Cash Flow

In the last 12 months, operating cash flow was 80.97 billion and capital expenditures -25.32 billion, giving a free cash flow of 55.65 billion.

Operating Cash Flow	80.97B
Capital Expenditures	-25.32B
Free Cash Flow	55.65B
FCF Per Share	3,811.71

Margins

Gross margin is 60.85%, with operating and profit margins of 31.97% and 25.48%.

Gross Margin	60.85%
Operating Margin	31.97%
Pretax Margin	32.53%
Profit Margin	25.48%
EBITDA Margin	36.29%
EBIT Margin	31.97%
FCF Margin	19.64%

Dividends & Yields

KRX:317450 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	15.52%
Buyback Yield	-0.59%
Shareholder Yield	-0.59%
Earnings Yield	6.72%
FCF Yield	5.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:317450 has an Altman Z-Score of 2.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.54
Piotroski F-Score	4